A research team has developed a causal deep learning model to personalize corticosteroid therapy for intensive care unit ...

INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...

I remember feeling like something really bad was about to happen.' ...

Since 2016, she has constantly had to use catheters, which is what has caused her sepsis each time. When Amani first got ...

Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company and its corporate parent, Shin Nippon Biomedical ...

According to the latest 2023 report from the World Health Organization (WHO), infectious diseases remain the leading cause of ...

Empiric concomitant coverage of MRSA and multidrug-resistant organisms is not necessary for most patients with sepsis.

First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

Gilead Sciences, Inc. and Kite, a Gilead Company, will present 21 abstracts, including 5 oral presentations, during the 67th American Society of Hematology (ASH) Annual Meeting and Exposition ...

Objectives To characterise the aetiological spectrum of thoracic granulomatous diseases and identify diagnostic features that facilitate differentiation among causes. Design Retrospective multicentre ...